… Total immunosuppression withdrawal (TIW) without causing rejection has been reported
in stable liver recipients. The role of ursodeoxycholic acid (UDCA) and patient characteristics …

… part of the initial immunosuppressive regimen or added after … Ten patients were withdrawn
from the study, 6 in the and g-… the only reason necessitating withdrawal of portal inflammation; …

… Ursodeoxycholic acid (UDCA) is commonly used to treat … Immunosuppression is presumed
to be important for children … (7,9) Ursodeoxycholic acid (UDCA) has been a mainstay of …

… ) and choleuretic agents (ursodeoxycholic acid) was given. … rose after withdrawal of the
immunosuppressive agents and … of immunosuppressive agents and ursodeoxycholic acid may …

… ursodeoxycholic acid (UDCA) and placebo groups after complete immunosuppression
withdrawal… We have shown that late total immunosuppression withdrawal in stable liver transplant …

… , ursodeoxycholic acid can reduce the expression of MHC-associated molecules on biliary
and central vein epithelial cells. However, attempts to use ursodeoxycholic acid to induce …

… on azathioprine and ursodeoxycholic acid. From 2007 to 2009, … When azathioprine and
ursodeoxycholic acid treatments … corticosteroid withdrawal and a long-term immunosuppressive …

… benefit for UDCA in facilitating steroid withdrawal.27 However, 4 … steroids and/or increased
immunosuppression. An exception is … The ability of bile acids to act as immunosuppressant-…

… is generally responsive to immunosuppressive treatment, and … With appropriate
immunosuppressive treatment, the 10-year … within 1 year after immunosuppressive treatment …

… , complete immunosuppression withdrawal has … -immunosuppressed, it is currently not
possible to derive evidence-based guidelines on how to manage long-term immunosuppression …